(Q40613199)

22 September 2017

title

Pancreatic cancer growth is inhibited by blockade of VEGF-RII. (English)

1 reference

22 September 2017

1 reference

6

Markus W Büchler

1 reference

22 September 2017

8

Helmut Friess

1 reference

22 September 2017

1

Peter Büchler

1 reference

22 September 2017

2

Howard A Reber

1 reference

22 September 2017

9

Oscar J Hines

1 reference

22 September 2017

5

Mendel Roth

1 reference

22 September 2017

7

Robert S Lavey

1 reference

22 September 2017

Axel Ullrich

3

1 reference

22 September 2017

Mark Shiroiki

series ordinal

4

1 reference

22 September 2017

language of work or name

1 reference

1 November 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

134

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

772-782

1 reference

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

1 reference

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Vascular permeability factor, an endothelial cell mitogen related to PDGF

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

The impact of different types of surgery in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

The function of KGF in morphogenesis of epithelium and reepithelialization of wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900296-4

7 January 2021

10.1016/S0039-6060(03)00296-4

Identifiers

DOI

1 reference

22 September 2017

1 reference